Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04495946 · ClinicalTrials.gov registry record · NA
Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 3,894
- Enrollment target
NCT04495946 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 3,894 participants.
The verdict
NCT04495946, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,894 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if implementation of the Sepsis Transition and Recovery (STAR) program within a large healthcare system will improve outcomes for high-risk patients with suspected sepsis, while concurrently examining contextual factors related to STAR program delivery within routine care to generate knowledge of best practices for implementation and dissemination of post sepsis transitions of care. To address persistent morbidity and mortality for sepsis survivors, Atrium Health developed the Sepsis Treatment and Recovery (STAR) program which uses a nurse navigator to deliver a bundle of best-practice care elements for the delivery of longitudinal post-sepsis care for up to 90 days. These care elements are directed towards the specific challenges and sequelae following a sepsis hospitalization and include: 1) identification and treatment of new physical, mental, and cognitive deficits; 2) review and adjustment of medications; 3) surveillance of treatable conditions that commonly lead to poor outcomes including chronic conditions that may de-stabilize during sepsis and recovery; and 4) focus on palliative care when appropriate. ENCOMPASS (Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship) is an effectiveness-implementation hybrid type I trial, with the evaluation designed as a two-arm, pragmatic, stepped-wedge cluster randomized controlled trial conducted at eight regional hospitals in which each participating hospital begins in a usual care control phase and transitions to the STAR program intervention in a randomly assigned sequence. Patients are allocated to receive the treatment condition (i.e., usual care or STAR) assigned to their admission hospital at time of enrollment. ENCOMPASS will test the hypothesis that patients who receive care through the STAR program will have reduced mortality and hospital readmission assessed 90 days post index hospital discharge compared to patients who receive usual care.
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Sepsis Transition and Recovery (STAR) program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,894 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04495946
The ClinicalTrials.gov registry entry for NCT04495946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,894 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT04495946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04495946 about?
NCT04495946 is a clinical study titled "Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship". The purpose of this study is to evaluate if implementation of the Sepsis Transition and Recovery (STAR) program within a large healthcare system will improve outcomes for high-risk patients with suspected sepsis, while concurrently examining contextual factors related to STAR program delivery within...
What is the current status of trial NCT04495946?
This trial is currently completed. It is a NA study. The enrollment target is 3,894 participants. The study started on 2020-07-01. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT04495946?
The interventions under investigation include: Usual care (BEHAVIORAL), Sepsis Transition and Recovery (STAR) program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04495946?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.